Sarepta Therapeutics gets FDA green light to resume Elevidys for DMD
Go back to Sarepta Therapeutics gets FDA green light to resume Elevidys for DMD| SAREPTA THERAP (NASDAQ: SRPT) | Delayed: 22.03 +0.70 (3.28%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $21.33 | 52 Week High | $63.73 | |||
| Open | $21.33 | 52 Week Low | $8.00 | |||
| Day High | $22.45 | P/E | N/A | |||
| Day Low | $21.33 | EPS | $-5.69 | |||
| Volume | 185,470 | |||||
